Sooyeol Lim
Overview
Explore the profile of Sooyeol Lim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagano M, Tanabe K, Kamei K, Lim S, Nakamura H, Ito S
Infect Dis Ther
. 2024 Sep;
13(10):2155-2177.
PMID: 39254889
Introduction: Japan will be transitioning from the free-of-charge COVID-19 vaccination program to annual periodic vaccination under a national immunization program for old adults and high-risk patients from 2024 fall/winter season....
2.
Lau E, Kotlyar E, Makanji Y, Yu D, Tan J, Casorso J, et al.
J Med Econ
. 2024 Mar;
27(1):596-604.
PMID: 38488130
Aim: Bosentan, ambrisentan, and macitentan are endothelin receptor antagonists (ERAs), currently available in Australia for treatment of pulmonary arterial hypertension (PAH). This study assessed the comparative adherence of these ERAs...
3.
Omura J, Makanji Y, Tanabe N, Yu D, Tan J, Lim S, et al.
Pulm Ther
. 2023 Nov;
9(4):511-526.
PMID: 37991630
Introduction: Real-world data on the comparative effectiveness of endothelin receptor antagonists (ERAs; macitentan, bosentan, ambrisentan) for pulmonary arterial hypertension (PAH), particularly in Asian countries, are scarce. We evaluated the persistence...
4.
Atsumi T, Tan J, Chiang A, Yu D, Makanji Y, Wu D, et al.
Mod Rheumatol
. 2023 Sep;
34(4):741-749.
PMID: 37747781
Objectives: Real-world evidence regarding prevalence, patient characteristics, and treatment patterns for pulmonary arterial hypertension (PAH) related to systemic lupus erythematosus (SLE) in Japan is limited. Methods: We conducted a retrospective...
5.
Dasa V, Lim S, Heeckt P
Am J Orthop (Belle Mead NJ)
. 2018 Aug;
47(7).
PMID: 30075038
Osteoarthritis (OA) of the knee is a top cause of disability among the elderly. Total knee replacement (TKR) has been available as an effective and definite surgical method to treat...
6.
Dasa V, DeKoven M, Sun K, Scott A, Lim S
Drugs Context
. 2016 Jul;
5:212296.
PMID: 27403194
Background: Intra-articular injection of hyaluronic acid (HA) for knee osteoarthritis (OA) effectively reduces pain and delays total knee replacement (TKR) surgery; however, little is known about relative differences in clinical...
7.
Strand V, Lim S, Takamura J
BMC Musculoskelet Disord
. 2016 Jun;
17:240.
PMID: 27250845
Background: Gel-200 is a cross-linked hyaluronate single-injection device for treatment of osteoarthritis pain in the knee. This report summarizes new analyses of the safety of retreatment with Gel-200 from the...
8.
Altman R, Lim S, Steen R, Dasa V
PLoS One
. 2016 Jan;
11(1):e0148591.
PMID: 26824481
No abstract available.
9.
Altman R, Lim S, Steen R, Dasa V
PLoS One
. 2015 Dec;
10(12):e0145776.
PMID: 26694145
Background: The growing prevalence of osteoarthritis (OA) and the medical costs associated with total knee replacement (TKR) surgery for end-stage OA motivate a search for agents that can delay OA...
10.
Husted J, Lim S, Chow E, Greenwood C, Bassett A
Am J Med Genet B Neuropsychiatr Genet
. 2009 Jan;
150B(6):845-53.
PMID: 19180565
Neurocognitive deficits are considered promising endophenotypes for gene discovery in schizophrenia. Understanding the heritability and genetic inter-relationships of neurocognitive traits could support their use as alternatives to diagnosis. Participants were...